BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wilken L, Rimmelzwaan GF. Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design? Pathogens 2020;9:E470. [PMID: 32549226 DOI: 10.3390/pathogens9060470] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Rajamanickam A, Nathella PK, Venkataraman A, Varadarjan P, Kannan S, Pandiarajan AN, Renji RM, Elavarasan E, Thimmaiah A, Sasidaran K, Krishnamoorthy N, Natarajan S, Ramaswamy G, Sundaram B, Putlibai S, Hissar S, Selladurai E, Uma Devi KR, Nutman TB, Babu S. Unique cellular immune signatures of multisystem inflammatory syndrome in children. PLoS Pathog 2022;18:e1010915. [PMID: 36322537 DOI: 10.1371/journal.ppat.1010915] [Reference Citation Analysis]
2 Ma E, Cheng G. Host immunity and vaccine development against Dengue virus. Infectious Medicine 2022;1:50-8. [DOI: 10.1016/j.imj.2021.12.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Park J, Kim J, Jang YS. Current status and perspectives on vaccine development against dengue virus infection. J Microbiol 2022;60:247-54. [PMID: 35157223 DOI: 10.1007/s12275-022-1625-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kubinski M, Beicht J, Gerlach T, Volz A, Sutter G, Rimmelzwaan GF. Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise. Vaccines (Basel) 2020;8:E451. [PMID: 32806696 DOI: 10.3390/vaccines8030451] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 11.5] [Reference Citation Analysis]